FINWIRES · TerminalLIVE
FINWIRES

Keurig Dr Pepper Expected to Deliver Q1 Beat, RBC Says

By

Keurig Dr Pepper (KDP) is expected to deliver Q1 results that exceed Street consensus, with a favorable risk to reward position given the stock's year-to-date underperformance, RBC Capital Markets said Tuesday.

Q1 consumption data indicates low-single-digit growth, consisting of slightly faster growth sequentially in both US Refreshment Beverages and Coffee, according to the note.

However, consumption and reported numbers may differ, as Keurig expects benefit from the GHOST acquisition, but faces challenges from shipment timing, price elasticity in Mexico, and retailer inventory management in US Coffee, the firm noted. RBC said it believes these headwinds are already factored into consensus estimates.

As commodity prices have softened and tariffs have been removed, some competitors are lowering prices, analysts said. Keurig has not made any announcements so far about cutting coffee prices, but pricing actions across the category will be important to track, the brokerage said.

Keurig's guidance range this year is wide given the JDE Peet's acquisition, RBC said, adding that it expects the company to reiterate 2026 outlook.

While there is still negative sentiment surrounding the JDE Peet's acquisition, RBC said better leverage profiles have improved the overall outlook of the combination. Ultimately, the stock is cheap and coffee fundamentals seem to be improving, the brokerage added.

Keurig is scheduled to release its Q1 financial results before the market opens on Thursday.

RBC maintained an outperform rating on Keurig Dr Pepper with a price target of $42.

Price: $26.39, Change: $-0.11, Percent Change: -0.41%

Related Articles

Wire

IDP Education to Introduce Malaysia as Study Destination

IDP Education (ASX:IEL) expanded its range of study destinations by supporting students to study in Malaysia, according to a Tuesday statement.The company cited changing student preferences as a reason for the move, with growing demand for new destinations offering strong education quality, career outcomes, and affordable study options.The initial rollout will focus on a select number of markets as part of a phased pilot.IDP Education's shares declined 1% in recent trading on Tuesday.

ASX:IEL
Wire

Infratil Says Moody's Assigns CDC Data Centers 'Baa2' Rating, Stable Outlook

Infratil (NZE:IFT, ASX:IFT) said Moody's Ratings has assigned CDC Data Centers Australia its first public investment grade credit rating of "Baa2" with a stable outlook, according to Tuesday filings with the Australian and New Zealand bourses.The rating reflects CDC's strong financial position, stable long-term contracted revenues, and exceptionally long lease durations averaging 28.4 years, per the filing.The rating will enable CDC to improve access to capital markets, supporting further large-scale infrastructure development driven by rising demand from government, hyperscale cloud providers, and critical industries, the filing added.The company's Kiwi shares shed 1% in recent Tuesday trade.

ASX:IFTNZE:IFT
Wire

Spruce Biosciences Begins Public Offering of Stock, Prefunded Warrants; Shares Fall After Hours

Spruce Biosciences (SPRB) said late Monday it commenced an underwritten public offering of common shares or related prefunded warrants.The company expects to grant underwriters a 30-day option to buy up to 15% more stock at the public offering price, less underwriting discounts and commissions.The offering is subject to market and other conditions, Spruce said.Spruce shares fell 13% in after-hours trading.

$SPRB